Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. J. Pharm. Sci. (Online) ; 59: e22102, 2023. graf
Artigo em Inglês | LILACS | ID: biblio-1439521

RESUMO

Abstract EphrinB2 plays a critical role in tumor growth. In this study, we studied the antitumor activity of imperatorin derivative IMP-1 in renal cell carcinoma (RCC) by regulating EphrinB2 pathway.. Results showed that IMP-1 inhibited the proliferation of 786-O cells in a dose- and time-dependent manner. More importantly, knockdown and transfection of EphrinB2 altered the inhibitory effect of IMP-1 on the activity of 786-O cells. IMP-1 arrested 786-O cell cycle at G0/G1 phase by decreasing the expression of cyclin D1 and cyclin E. Moreover, IMP-1 regulated Bcl-2 family proteins' expression, thus inducing apoptosis of 786-O cells. IMP-1 down-regulated the expression of EphrinB2, Syntenin1 and PICK1. Then, IMP-1 decreased the phosphorylation of Erk1/2 and AKT. In all, IMP-1 could regulate the EphrinB2 pathway in order to inhibit 786-O cell growth by arresting the cell cycle at G0/G1 phase and inducing cell apoptosis. Thus, IMP-1 may present as a potential strategy for RCC treatment.


Assuntos
Carcinoma de Células Renais/patologia , Neoplasias/classificação , Fase G1/genética , Ciclina D1/efeitos adversos , Ciclina E/efeitos adversos
2.
Genet. mol. res. (Online) ; 6(1): 152-165, 2007. tab, ilus
Artigo em Inglês | LILACS | ID: lil-456761

RESUMO

The putative eukaryotic translation initiation factor 5A (eIF5A) is an essential protein for cell viability and the only cellular protein known to contain the unusual amino acid residue hypusine. eIF5A has been implicated in translation initiation, cell proliferation, nucleocytoplasmic transport, mRNA decay, and actin polarization, but the precise biological function of this protein is not clear. However, eIF5A was recently shown to be directly involved with the translational machinery. A screen for synthetic lethal mutations was carried out with one of the temperature-sensitive alleles of TIF51A (tif51A-3) to identify factors that functionally interact with eIF5A and revealed the essential gene YPT1. This gene encodes a small GTPase, a member of the rab family involved with secretion, acting in the vesicular trafficking between endoplasmatic reticulum and the Golgi. Thus, the synthetic lethality between TIF51A and YPT1 may reveal the connection between translation and the polarized distribution of membrane components, suggesting that these proteins work together in the cell to guarantee proper protein synthesis and secretion necessary for correct bud formation during G1/S transition. Future studies will investigate the functional interaction between eIF5A and Ypt1 in order to clarify this involvement of eIF5A with vesicular trafficking.


Assuntos
Genes Letais/genética , Mutação/genética , Fatores de Iniciação de Peptídeos/genética , Proteínas de Ligação a RNA/genética , Proteínas de Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/genética , Proteínas rab de Ligação ao GTP/genética , Fase G1/genética , Fase S/genética , Saccharomyces cerevisiae/citologia , Vesículas Transportadoras/genética
3.
Genet. mol. res. (Online) ; 2(3): 328-333, Sept. 2003.
Artigo em Inglês | LILACS | ID: lil-417597

RESUMO

Hydroxyurea is considered an antineoplastic drug, which also plays an important role in the treatment of sickle cell anemia patients. We evaluated and compared the clastogenic and cytotoxic effects of hydroxyurea, using chromosomal aberrations and mitotic index, respectively, as endpoints. In vitro short-term cultures of lymphocytes were exposed to several concentrations of this drug, at various cell cycle phases. There was a significant increase in the cytotoxicity of hydroxyurea at G1 and G1/S as well in the G2 phase of the cell cycle. Hydroxyurea did not significantly increase chromosome aberrations. There was an S-dependent cytotoxic effect of hydroxyurea, which is expected based on the known activity of hydroxyurea as an inhibitor of ribonucleotide reductase


Assuntos
Humanos , Aberrações Cromossômicas/induzido quimicamente , Antineoplásicos/toxicidade , Hidroxiureia/toxicidade , Interfase/efeitos dos fármacos , Linfócitos/efeitos dos fármacos , Análise de Variância , Determinação de Ponto Final , Fase G1/efeitos dos fármacos , Fase G1/genética , /efeitos dos fármacos , /genética , Fase S/efeitos dos fármacos , Fase S/genética , Interfase/genética , Índice Mitótico , Testes de Mutagenicidade/métodos
4.
Ciênc. cult. (Säo Paulo) ; 46(1/2): 86-7, Jan.-Abr. 1994. tab
Artigo em Inglês | LILACS | ID: lil-172016

RESUMO

A genetic approach was adopted to analyze the cell cycle G(O)(G (1) (S transition in mouse Balb/ 3T3 fibroblasts (clone A3l). We designed selection procedures to isolate revertant from the EJ-ras transformed Balb/3T3 ribroblasts that had recovered strict -control of the G(O) ( G(1), transition by serum growth factors. The aim was to uncover phenotypic traits associated with malignancy (high growth rate G(1) phase shortening and high tumorigenicity) that segregate independently.


Assuntos
Animais , Camundongos , Células Clonais , Divisão Celular/genética , Fase G1/genética , Regulação da Expressão Gênica/fisiologia , Substâncias de Crescimento , Fase de Repouso do Ciclo Celular/genética , Fase S/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA